Gennex Laboratories Limited (GENNEX.BO)
INR 17.5
(-0.74%)
INR 17.5
(-0.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -459.67 Million | -144.5 Million | 66.36 Million | -14.37 Million | -16.71 Million | 18.75 Million |
| Net Income | 131.75 Million | 60.11 Million | 52.75 Million | 50.62 Million | 25.48 Million | 30.27 Million |
| Depreciation & Amortization | 23.67 Million | 7.44 Million | 7.88 Million | 8.8 Million | 10.04 Million | 9.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -648.27 Million | -197.25 Million | -955 Thousand | -65.35 Million | -58.95 Million | -25.31 Million |
| Other non-cash items | 238.79 Million | -14.8 Million | 6.67 Million | -8.44 Million | 6.7 Million | 3.95 Million |
| Investing Cash Flow | 151.18 Million | -7.65 Million | -12.61 Million | -249.59 Thousand | -2.15 Million | -9.94 Million |
| Investments in PPE | - | -22.22 Million | -3.89 Million | -787.75 Thousand | -2.94 Million | -10.41 Million |
| Acquisitions | 153.53 Million | 500 Thousand | 286.9 Thousand | - | - | - |
| Investment purchases | -2.34 Million | -12.54 Million | - | - | - | - |
| Sales/Maturities of investments | - | 26.61 Million | - | - | - | - |
| Other Investing Activities | -2.34 Million | -1000.00 | -9 Million | 538.16 Thousand | 793.04 Thousand | 471.94 Thousand |
| Financing Cash Flow | 767.59 Million | 213.54 Million | 18.68 Million | 16.18 Million | -3.47 Million | 12.46 Million |
| Debt repayment | -30.71 Million | -80.52 Million | -155 Thousand | -154.9 Thousand | -394.43 Thousand | -3.76 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 798.31 Million | 304.39 Million | - | - | - | - |
| Other Financing Activities | 767.55 Million | -10.32 Million | 18.84 Million | 16.34 Million | -3.07 Million | 16.23 Million |
| Accounts receivables | -83.94 Million | 18.96 Million | -23.67 Million | -26.66 Million | 41.18 Million | 614 Thousand |
| Accounts payables | 20.49 Million | 124.46 Million | 22.12 Million | -39.32 Million | 22.62 Million | -32.79 Million |
| Inventory | -94.82 Million | -72.35 Million | -27.18 Million | 24.18 Million | -21.1 Million | -29.88 Million |
| Other working capital | -490 Million | -268.33 Million | 27.76 Million | -23.55 Million | -101.65 Million | 36.74 Million |
| Cash at beginning of period | 150.64 Million | 83.12 Million | 10.69 Million | 9.12 Million | 31.46 Million | 10.18 Million |
| Cash at end of period | 609.75 Million | 144.51 Million | 83.12 Million | 10.69 Million | 9.12 Million | 31.46 Million |
| Capital Expenditure | - | -22.22 Million | -3.89 Million | -787.75 Thousand | -2.94 Million | -10.41 Million |
| Effect of forex changes on cash | - | -1000.00 | - | - | - | 1.00 |
| Net cash flow / Change in cash | 459.1 Million | 61.38 Million | 72.43 Million | 1.56 Million | -22.33 Million | 21.28 Million |
| Free Cash Flow | -459.67 Million | -166.72 Million | 62.46 Million | -15.15 Million | -19.65 Million | 8.34 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 131.75 Million | 44.95 Million | 27.64 Million | 30.65 Million | 28.49 Million | 60.11 Million |
| Depreciation & Amortization | 23.67 Million | - | 4.54 Million | 10.34 Million | 6.48 Million | 7.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -648.27 Million | - | - | - | - | -197.25 Million |
| Other non-cash items | 238.79 Million | -44.95 Million | -27.64 Million | -30.65 Million | -28.49 Million | -14.8 Million |
| Investing Cash Flow | 151.18 Million | - | - | - | - | -7.65 Million |
| Investments in PPE | - | - | - | - | - | -22.22 Million |
| Acquisitions | 153.53 Million | - | - | - | - | 500 Thousand |
| Investment purchases | -2.34 Million | - | - | - | - | -12.54 Million |
| Sales/Maturities of investments | - | - | - | - | - | 26.61 Million |
| Other Investing Activities | -2.34 Million | - | - | - | - | -1000.00 |
| Financing Cash Flow | 767.59 Million | - | - | - | - | 213.54 Million |
| Debt repayment | -30.71 Million | - | - | - | - | -80.52 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 798.31 Million | - | - | - | - | 304.39 Million |
| Other Financing Activities | 767.55 Million | - | - | - | - | -10.32 Million |
| Accounts receivables | -83.94 Million | - | - | - | - | 18.96 Million |
| Accounts payables | 20.49 Million | - | - | - | - | 124.46 Million |
| Inventory | -94.82 Million | - | - | - | - | -72.35 Million |
| Other working capital | -490 Million | - | - | - | - | -268.33 Million |
| Cash at beginning of period | 150.64 Million | - | 97.73 Million | 67.07 Million | 150.64 Million | 83.12 Million |
| Cash at end of period | 609.75 Million | - | 106.81 Million | 97.73 Million | 28.49 Million | 144.51 Million |
| Capital Expenditure | - | - | - | - | - | -22.22 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1000.00 |
| Net cash flow / Change in cash | 459.1 Million | - | 9.08 Million | 30.65 Million | -122.14 Million | 61.38 Million |
| Free Cash Flow | -459.67 Million | - | 9.08 Million | 30.65 Million | 28.49 Million | -166.72 Million |
600444
DLPRF
SNNAF
CGI
SVCTF
FAST